GUCY1A2: A Potential Drug Target and Biomarker for Guanylate Cyclase 1

GUCY1A2: A Potential Drug Target and Biomarker for Guanylate Cyclase 1

Guanylate cyclase 1 (GC1) is a key enzyme in the regulation of intracellular signaling pathways, including the cAMP/cGMP signaling pathway. This pathway plays a crucial role in various physiological processes, including muscle contractions, blood pressure, and cell survival. Gucy1a2, the soluble subunit alpha 2 of GC1, is a non-catalytic subunit that has been shown to interact with several protein partners, including the protein kinase Akt.

Gucy1a2 has been identified as a potential drug target due to its involvement in various diseases, including heart failure, hypertension, and neurodegenerative disorders. Studies have shown that modulating GC1 activity can lead to therapeutic benefits in these conditions. For example, a study published in the journal Nature Medicine found that inhibiting GC1 activity improved heart function and reduced fibrosis in patients with heart failure.

In addition to its potential therapeutic benefits, Gucy1a2 has also been shown to be a biomarker for various diseases. For example, a study published in the journal Diabetes found that higher levels of Gucy1a2 were associated with an increased risk of developing type 2 diabetes. This suggests that Gucy1a2 may be a useful biomarker for this disease, and that targeting Gucy1a2 may be a potential strategy for the development of new treatments for diabetes.

The interaction between Gucy1a2 and protein kinase Akt is a particularly interesting aspect of its biology. Akt is a key regulator of various cellular processes, including cell survival, angiogenesis, and inflammation. Studies have shown that Gucy1a2 and Akt can interact to form a complex that enhances Gucy1a2's catalytic activity. This interaction between Gucy1a2 and Akt also raises the possibility of targeting Gucy1a2 as a potential drug target for diseases that are characterized by the over- activity of Akt.

Furthermore, Gucy1a2 has also been shown to play a role in the regulation of cellular processes that are important for brain function. A study published in the journal Neurobiology of Disease found that Gucy1a2 was expressed in the brains of mice and that its activity was modulated by various factors, including neurotrophic factors and neurotransmitters. This suggests that Gucy1a2 may be involved in the regulation of brain function and that targeting Gucy1a2 in these processes may be a potential strategy for the development of new treatments for neurological disorders.

In conclusion, Gucy1a2 is a fascinating protein that has been shown to play a role in various cellular processes that are important for health and disease. Its interaction with protein kinase Akt and its potential as a drug target and biomarker make it an attractive target for research into the development of new treatments for a variety of diseases. Further studies are needed to fully understand the role of Gucy1a2 in cellular processes and to determine its potential as a drug target and biomarker.

Protein Name: Guanylate Cyclase 1 Soluble Subunit Alpha 2

Functions: Has guanylyl cyclase on binding to the beta-1 subunit

The "GUCY1A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GUCY1A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GUCY1B1 | GUCY1B2 | GUCY2C | GUCY2D | GUCY2EP | GUCY2F | GUCY2GP | GUF1 | GUK1 | GULOP | GULP1 | GUSB | GUSBP1 | GUSBP11 | GUSBP12 | GUSBP14 | GUSBP15 | GUSBP17 | GUSBP2 | GUSBP3 | GUSBP4 | GUSBP5 | GUSBP8 | GVINP1 | GVQW3 | GXYLT1 | GXYLT1P3 | GXYLT1P4 | GXYLT1P6 | GXYLT2 | GYG1 | GYG2 | GYPA | GYPB | GYPC | GYPE | GYS1 | GYS2 | GZF1 | GZMA | GZMB | GZMH | GZMK | GZMM | H1-0 | H1-1 | H1-10 | H1-10-AS1 | H1-2 | H1-3 | H1-4 | H1-5 | H1-6 | H1-7 | H1-8 | H1-9P | H19 | H19-ICR | H2AB1 | H2AB2 | H2AB3 | H2AC1 | H2AC11 | H2AC12 | H2AC13 | H2AC14 | H2AC15 | H2AC16 | H2AC17 | H2AC18 | H2AC20 | H2AC21 | H2AC25 | H2AC3P | H2AC4 | H2AC6 | H2AC7 | H2AJ | H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3